News & Events

24 June, 2020

BrainsWay Reports First Quarter 2020 Financial Results and Operational Highlights

PATTERSON, N.J. and JERUSALEM, Israel, June 24, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

16 June, 2020

BrainsWay Launches New Website to Enhance Mental Health Awareness

New site features user-friendly layout, easy access to resources, and tools for those affected by COVID-19

11 June, 2020

BrainsWay Announces Participation in a Virtual Fireside Chat at the Raymond James 2020 Human Health Innovation Conference

PATTERSON, N.J. and JERUSALEM, Israel, June 11, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

9 June, 2020

BrainsWay to Report First Quarter 2020 Financial Results and Operational Highlights on June 24, 2020

PATTERSON, N.J. and JERUSALEM, Israel, June 9, 2020 — BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

20 May, 2020

BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global Marketing

PATTERSON, N.J., May 20, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

6 May, 2020

BrainsWay Enhances Senior Leadership with Promotion and New Executive Addition

Hadar Levy Promoted to Senior Vice President and General Manager of North America Company Appoints Seasoned...

13 April, 2020

BrainsWay Announces Preliminary Revenue Range for First Quarter of 2020

PATTERSON, N.J., April 13, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...

23 March, 2020

BrainsWay Reports Fourth Quarter and Full-Year 2019 Financial Results and Operational Highlights

Fourth quarter revenues were $6.3 million, up 32% over the same quarter in the prior year.

15 March, 2020

BrainsWay Announces Positive Data from Smoking Cessation Multicenter Study Evaluating Use of Deep TMS at Society for Research on Nicotine & Tobacco 2020

Positive results showed that Deep TMS may help chronic smokers quit – Data collected from first multicenter...

10 February, 2020

BrainsWay Reports Results of Interim Analysis of H7 Deep Transcranial Magnetic Stimulation Study in Post-Traumatic Stress Disorder

Company to discontinue funding of study following insufficient demonstration of efficacy

10 February, 2020

BrainsWay Appoints Avner Lushi to Join Board of Directors

Lushi also to serve on Company’s audit committee

10 February, 2020

BrainsWay Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System in the treatment of Adults with ADHD

Results demonstrate increased activity in attention-related brain networks treated with BrainsWay’s...

2 December, 2019

BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in Smoking Cessation

Primary and secondary endpoint achieved with statistical significance. Company intends to meet with...

25 November, 2019

BrainsWay Reports Third Quarter 2019 Financial Results and Operational Highlights

Third quarter revenues were $5.9 million, up 38% over the same quarter in the prior year

25 November, 2019

BrainsWay Appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer

JERUSALEM and HACKENSACK, N.J., Nov. 25, 2019 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) and its...

25 November, 2019

BrainsWay‘s New Stimulator for Deep Transcranial Magnetic Stimulation Makes German Debut at the 2019 German Association for Psychiatry, Psychotherapy and Psychosomatics Congress

JERUSALEM, Nov. 25, 2019 – BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced...

1 October, 2019

BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting

JERUSALEM, Oct. 01, 2019 – BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced...